Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00734929 · ClinicalTrials.gov registry record · Phase 4
Aprepitant With Dexamethasone Versus Ondansetron With Dexamethasone for PONV Prophylaxis in Patients Having Craniotomy
A Phase 4 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 4
- Development phase
- 115
- Enrollment target
NCT00734929 is a Phase 4 study that has completed, run by Duke University. The registered enrollment target is 115 participants.
The verdict
NCT00734929, a Phase 4 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 115 participants
- Enrollment target
Study Summary
We hypothesize that the combination of aprepitant with dexamethasone will provide significantly improved prophylaxis against Postoperative nausea and vomiting compared with the combination of ondansetron and dexamethasone, in patients undergoing craniotomy under general anesthesia.
Interventions
- DRUG Aprepitant + Dexamethasone
- DRUG Ondansetron + Dexamethasone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2007-09 |
| Est. Completion | 2009-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00734929
The ClinicalTrials.gov registry entry for NCT00734929 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 115 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Aprepitant + Dexamethasone is the first listed.
NCT00734929 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00734929 about?
NCT00734929 is a clinical study titled "Aprepitant With Dexamethasone Versus Ondansetron With Dexamethasone for PONV Prophylaxis in Patients Having Craniotomy". We hypothesize that the combination of aprepitant with dexamethasone will provide significantly improved prophylaxis against Postoperative nausea and vomiting compared with the combination of ondansetron and dexamethasone, in patients undergoing craniotomy under general anesthesia.
What is the current status of trial NCT00734929?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 115 participants. The study started on 2007-09. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00734929?
The interventions under investigation include: Aprepitant + Dexamethasone (DRUG), Ondansetron + Dexamethasone (DRUG).
Who is sponsoring clinical trial NCT00734929?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.